CXCL16 and myocardial infarction: In the murine model of myocardial infarction, CXCL16-mediated activation of NF-κB and p38MAPK pathways drives upregulation of CCL4 and CCL5, resulting in amplified monocyte recruitment and subsequent aggravation of cardiac injury (54).